Fact CheckerSign in

NCT05858437Recruiting

Impact of Propionic Acid on Regulatory T Cell Function in Children With CKD

Impact of Propionic Acid on Regulatory T Cell Function in Children With Chronic Kidney Disease

Source: ClinicalTrials.gov · Last updated 4 Nov 2026

Brief summary (registry, in English)

Pro-Kids is a multi-center, double-blind, randomized and placebo-controlled intervention study in children with chronic kidney disease. The investigators address the effect of a dietary food supplementation of propionic acid on the immune system and the function of the intestinal barrier in CKD patients treated with hemodialysis.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
16 (estimated)
First submitted
25 Apr 2023
Start date
15 Jan 2024
Primary completion date
8 Jul 2026
Lead sponsor
Charite University, Berlin, Germany
NCT number
NCT05858437

What you commit to

  • Study type: Interventional
  • Planned participants: 16
  • From 15 Jan 2024 to the primary completion date, 8 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Immunosuppressive therapy within the last 12 weeks before the start of the study
  • Pre-/pro- or postbiotic or antibiotic therapy within the last 4 weeks before the start of the study
  • Planned or unplanned hospitalization within in last 4 weeks before the start of the study or during study
  • alcohol- or drug abuse

Other illness

  • Disease or dysfunctions, which disqualifies the patient
  • Acute infections
  • Malignant diseases
  • chronic gastrointestinal or hepatic diseases (for example chronic inflammatory bowel disease

Other

  • Incapacity of contract or any other circumstances, which prohibit the patient or his legal guardians from understanding setup, meaning and entity of the study
  • Pregnancy
  • parallel participation on other interventional trials

Who the study is looking for

  • Body weight: \> 30kg
  • CKD G5 treated with hemodialysis
  • Continuous hemodialysis treatment for \> 3 months
  • Clinical stable condition
  • Manifestation of CKD within childhood (\<18 years)

Age in the registry: 12 years to 20 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité-Universitätsmedizin Berlin
Coordinator of this site? Confirm its status
BerlinGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.